Eyestem’s Series B Funding Propels Valuation Up by 70%
Eyestem Research raised $10M in Series B, with a valuation of Rs 592 crore, developing eye disease therapies.
Read moreDetailsADVERTISEMENT
Eyestem Research Secures $10 Million in Series B Funding
Eyestem Research raised $10 million to advance its Phase 2 clinical trial for dry AMD treatments.
Read moreDetailsADVERTISEMENT
StartupSuperb
Research-backed Indian startup journalism. Funding rounds, mergers and acquisitions, AI, and technology — every figure checked against primary sources.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.